ATR · earnings call history
AptarGroup Q2 FY26 — Adjusted EPS above guidance, strong Pharma performance
Read the briefAptarGroup Q1 FY26 — Mixed Performance with Pharma Destocking and Operational Challenges
Read the briefBrowse all US companies on the earnings-call register.